Musunuru provided ESGCT delegates with promising news of a roadmap following the diagnosis and treatment of Baby KJ.
In April 2025, AstraZeneca announced that its experimental oral PCSK9 inhibitor, AZD0780, achieved a 50.7% reduction in LDL ...
CRISPR therapies offer precise gene-editing solutions for treating genetic disorders and other complex diseases. Rising prevalence of genetic conditions drives adoption, and emerging CRISPR-based ...
AIRNA, a biotech company pioneering RNA editing therapeutics to transform the lives of patients with rare and common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results